Literature DB >> 889677

Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.

J A Stanley, W U Shipley, G G Steel.   

Abstract

Radiation survival curves for Lewis lung tumours in the lungs ranging in size from 0-5 to 20 mm3 have been obtained, and a size-dependent variation in hypoxic fraction was found. Cell-survival studies following treatment of various sizes of s.c. tumours indicated that the effects of 60Co gamma-rays and the chemotherapeutic agents 1,3-bas(2-chloroethyl)-1-nitrosourea (BCNU) and cyclophosphamide are all size-dependent. Large pulmonary nodules which had regressed but had not been cured by cyclophosphamide regrew with a radiosensitivity that was characteristic of previously untreated tumours. The results give additional experimental support to the clinical interest in early adjuvant therapy of micrometastases, and sequential combined modality therapy for larger tumours.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889677      PMCID: PMC2025447          DOI: 10.1038/bjc.1977.160

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  M L Rosenblum; K T Wheeler; C B Wilson; M Barker; K D Knebel
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

2.  Radiation response of artificial pulmonary metastases of the EMT6 tumor.

Authors:  K K Fu; T L Phillips; M D Wharam
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

3.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

4.  The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.

Authors:  R M Heyn; R Holland; W A Newton; M Tefft; N Breslow; J R Hartmann
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

5.  Tumor chemotherapy: efficacy dependent on mode of growth.

Authors:  R F Hagemann; L L Schenken; S Lesher
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

6.  A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.

Authors:  W D DeWys
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

7.  Oxygen diffusion and the distribution of cellular radiosensitivity in tumours.

Authors:  I F Tannock
Journal:  Br J Radiol       Date:  1972-07       Impact factor: 3.039

8.  Size dependence of the response of Lewis lung tumors to BCNU.

Authors:  G G Steel; K Adams; J Stanley
Journal:  Cancer Treat Rep       Date:  1976-12

9.  Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors.

Authors:  K SUGIURA; C C STOCK
Journal:  Cancer Res       Date:  1955-01       Impact factor: 12.701

10.  The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  22 in total

1.  Adenosine-5'-triphosphate levels in experimental CaNT and Fib/t tumours of varying volume and degree of hypoxia.

Authors:  D Szeinfeld
Journal:  Experientia       Date:  1988-03-15

2.  Influence of tumour size on radiosensitization by misonidazole.

Authors:  J A Stanley; M J Peckham; G G Steel
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.

Authors:  B A Teicher; S D Bernal; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  CAI: effects on cytotoxic therapies in vitro and in vivo.

Authors:  B A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics.

Authors:  Xuefeng Gao; J Tyson McDonald; Lynn Hlatky; Heiko Enderling
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

8.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities.

Authors:  D W Siemann
Journal:  Br J Cancer Suppl       Date:  1980-04

10.  Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.

Authors:  B A Teicher; T T Korbut; K Menon; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.